Display options
Cite
Fujisawa C, Castellot JJ. Matrix production and remodeling as therapeutic targets for uterine leiomyoma. J Cell Commun Signal. 2014;8(3):179-94doi: 10.1007/s12079-014-0234-x.
Fujisawa, C., & Castellot, J. J. (2014). Matrix production and remodeling as therapeutic targets for uterine leiomyoma. Journal of cell communication and signaling, 8(3), 179-94. https://doi.org/10.1007/s12079-014-0234-x
Fujisawa, Caitlin, and Castellot, John J. "Matrix production and remodeling as therapeutic targets for uterine leiomyoma." Journal of cell communication and signaling vol. 8,3 (2014): 179-94. doi: https://doi.org/10.1007/s12079-014-0234-x
Fujisawa C, Castellot JJ. Matrix production and remodeling as therapeutic targets for uterine leiomyoma. J Cell Commun Signal. 2014 Sep;8(3):179-94. doi: 10.1007/s12079-014-0234-x. Epub 2014 Jul 11. PMID: 25012731; PMCID: PMC4165822.
Copy Download .nbib Format: NLM
Share it on

J Cell Commun Signal. 2014 Sep;8(3):179-94. doi: 10.1007/s12079-014-0234-x. Epub 2014 Jul 11.

Matrix production and remodeling as therapeutic targets for uterine leiomyoma.

Journal of cell communication and signaling

Caitlin Fujisawa, John J Castellot

Affiliations

  1. Public Heath and Professional Degrees Program, Tufts University School of Medicine, Boston, MA, 02111, USA.

PMID: 25012731 PMCID: PMC4165822 DOI: 10.1007/s12079-014-0234-x

Abstract

Uterine leiomyoma, commonly known as fibroids, is a benign neoplasm of smooth muscle in women. The incidence of clinically symptomatic fibroids in reproductive-age women is approximately 20 %, with nearly 80 % of black women suffering from this condition. Symptoms include severe pain and hemorrhage; fibroids are also a major cause of infertility or sub-fertility in women. Uterine leiomyoma consist of hyperplastic smooth muscle cells and an excess deposition of extracellular matrix, specifically collagen, fibronectin, and sulfated proteoglycans. Extracellular matrix components interact and signal through integrin-β1 on the surface of uterine leiomyoma smooth muscle cells, provide growth factor storage, and act as co-receptors for growth factor-receptor binding. ECM and growth factor signaling through integrin-β1 and growth factor receptors significantly increases cell proliferation and ECM deposition in uterine leiomyoma. Growth factors TGF-β, IGF, PDGF, FGF and EGF are all shown to promote uterine leiomyoma progression and signal through multiple pathways to increase the expression of genes encoding matrix or matrix-modifying proteins. Decreasing integrin expression, reducing growth factor action and inhibiting ECM action on uterine leiomyoma smooth muscle cells are important opportunities to treat uterine leiomyoma without use of the current surgical procedures. Both natural compounds and chemicals are shown to decrease fibrosis and uterine leiomyoma progression, but further analysis is needed to make inroads in treating this common women's health issue.

References

  1. Fertil Steril. 2010 Mar 15;93(5):1500-8 - PubMed
  2. Am J Obstet Gynecol. 1995 Aug;173(2):571-7 - PubMed
  3. PLoS One. 2013 Sep 11;8(9):e75844 - PubMed
  4. J Cell Biol. 1997 Apr 7;137(1):231-45 - PubMed
  5. Cell Commun Signal. 2010 Jun 10;8:10 - PubMed
  6. Gynecol Obstet Invest. 2004;58(1):14-8 - PubMed
  7. J Clin Endocrinol Metab. 2013 May;98(5):E837-46 - PubMed
  8. J Cell Biol. 1993 May;121(3):679-87 - PubMed
  9. Gynecol Obstet Invest. 2013;75(3):185-90 - PubMed
  10. Reprod Biol Endocrinol. 2012 Dec 17;10:111 - PubMed
  11. J Theor Biol. 2005 Apr 21;233(4):483-99 - PubMed
  12. J Clin Endocrinol Metab. 2004 Nov;89(11):5549-57 - PubMed
  13. Mol Hum Reprod. 2013 Jun;19(6):380-7 - PubMed
  14. Nat Rev Cancer. 2004 Nov;4(11):839-49 - PubMed
  15. J Clin Endocrinol Metab. 2011 Apr;96(4):E754-62 - PubMed
  16. Cancer Res. 1986 Mar;46(3):1015-29 - PubMed
  17. J Vasc Interv Radiol. 2013 Jun;24(6):765-71 - PubMed
  18. J Cell Biol. 1989 Jul;109(1):317-30 - PubMed
  19. Scand J Rheumatol Suppl. 1991;88:7-15 - PubMed
  20. Gynecol Obstet Invest. 2011;71(2):129-35 - PubMed
  21. Fertil Steril. 1992 Jul;58(1):66-71 - PubMed
  22. Cancer Biol Ther. 2006 Jan;5(1):28-33 - PubMed
  23. Semin Cell Dev Biol. 2014 Aug;32:107-18 - PubMed
  24. Lab Invest. 1989 Jan;60(1):30-7 - PubMed
  25. J Cell Sci. 2002 Oct 15;115(Pt 20):3861-3 - PubMed
  26. Biochimie. 2001 Jun;83(6):529-36 - PubMed
  27. Fertil Steril. 2009 May;91(5 Suppl):2177-84 - PubMed
  28. Curr Opin Cell Biol. 2003 Oct;15(5):572-82 - PubMed
  29. J Biol Chem. 2007 Nov 30;282(48):35308-17 - PubMed
  30. Int J Womens Health. 2014 Jan 29;6:95-114 - PubMed
  31. Biochimie. 2006 Feb;88(2):141-6 - PubMed
  32. Gynecol Obstet Invest. 1992;34(2):111-4 - PubMed
  33. Biomaterials. 2011 Oct;32(28):6737-44 - PubMed
  34. Oncology. 2002;63(4):317-32 - PubMed
  35. Fertil Steril. 2007 Jun;87(6):1399-412 - PubMed
  36. Fertil Steril. 2009 Jun;91(6):2664-75 - PubMed
  37. AAPS J. 2009 Sep;11(3):495-510 - PubMed
  38. Am J Pathol. 2003 Oct;163(4):1653-62 - PubMed
  39. Fertil Steril. 2004 Oct;82 Suppl 3:1182-7 - PubMed
  40. Gynecol Oncol. 2004 Jan;92(1):47-56 - PubMed
  41. J Soc Gynecol Investig. 2006 Dec;13(8):542-50 - PubMed
  42. J Biol Chem. 2002 Nov 22;277(47):45361-70 - PubMed
  43. J Clin Endocrinol Metab. 2009 May;94(5):1768-74 - PubMed
  44. Biochem J. 2012 Apr 15;443(2):361-8 - PubMed
  45. Biol Reprod. 2009 Oct;81(4):749-58 - PubMed
  46. Hum Reprod. 1993 Nov;8(11):1796-806 - PubMed
  47. J Drugs Dermatol. 2013 Apr;12(4):458-63 - PubMed
  48. Hum Reprod. 2014 Mar;29(3):490-501 - PubMed
  49. Fertil Steril. 2012 Dec;98(6):1557-62 - PubMed
  50. J Clin Endocrinol Metab. 2001 Feb;86(2):913-20 - PubMed
  51. Biochim Biophys Acta. 2014 Feb;1843(2):335-45 - PubMed
  52. Hum Reprod. 1996 Aug;11(8):1724-30 - PubMed
  53. FASEB J. 1997 Jan;11(1):51-9 - PubMed
  54. Hum Reprod. 2007 Oct;22(10):2623-31 - PubMed
  55. Mol Med. 2008 May-Jun;14(5-6):264-75 - PubMed
  56. J Clin Invest. 1997 Nov 15;100(10):2596-605 - PubMed
  57. Biochem J. 1987 Nov 1;247(3):597-604 - PubMed
  58. Semin Cell Dev Biol. 2014 Apr;28:2-11 - PubMed
  59. J Theor Biol. 2006 Jan 7;238(1):124-45 - PubMed
  60. Hum Reprod. 2005 Jun;20(6):1456-65 - PubMed
  61. Hum Reprod. 2008 Apr;23(4):944-51 - PubMed
  62. Epidemiology. 2013 May;24(3):447-53 - PubMed
  63. J Orthop Res. 2014 Apr;32(4):515-23 - PubMed
  64. Am J Obstet Gynecol. 2003 Jan;188(1):100-7 - PubMed
  65. J Signal Transduct. 2012;2012:204236 - PubMed
  66. J Assist Reprod Genet. 2012 Aug;29(8):703-12 - PubMed
  67. Matrix Biol. 2012 Jan;31(1):57-65 - PubMed
  68. Sci Transl Med. 2011 Sep 14;3(100):100ra89 - PubMed
  69. J Dev Physiol. 1991 Feb;15(2):105-10 - PubMed
  70. Cell Prolif. 2013 Aug;46(4):408-15 - PubMed
  71. J Obstet Gynaecol Res. 2000 Oct;26(5):325-31 - PubMed
  72. Am J Physiol Cell Physiol. 2007 May;292(5):C1701-13 - PubMed
  73. Mol Cell Biochem. 1998 Dec;189(1-2):145-52 - PubMed
  74. Am J Obstet Gynecol. 2012 Mar;206(3):211.e1-9 - PubMed
  75. Best Pract Res Clin Obstet Gynaecol. 2008 Aug;22(4):589-601 - PubMed
  76. Arch Biochem Biophys. 2013 Nov 15;539(2):171-80 - PubMed
  77. J Endocrinol. 2002 Jan;172(1):83-93 - PubMed
  78. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6844-8 - PubMed
  79. Hum Pathol. 2014 Mar;45(3):481-7 - PubMed
  80. Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4563-8 - PubMed
  81. Am J Obstet Gynecol. 2008 Apr;198(4):474.e1-11 - PubMed
  82. Exp Ther Med. 2011 Mar;2(2):287-290 - PubMed
  83. J Clin Endocrinol Metab. 2013 Aug;98(8):E1374-8 - PubMed
  84. Int Rev Immunol. 1995;12(2-4):177-85 - PubMed
  85. J Biol Chem. 1995 May 12;270(19):11555-66 - PubMed
  86. Obstet Gynecol. 1997 Dec;90(6):967-73 - PubMed
  87. BMC Womens Health. 2012 Mar 26;12:6 - PubMed
  88. Mol Pathol. 2001 Oct;54(5):311-6 - PubMed
  89. Nat Rev Cancer. 2009 Feb;9(2):108-22 - PubMed
  90. Nature. 1990 Jul 19;346(6281):281-4 - PubMed
  91. Expert Opin Investig Drugs. 2014 Mar;23(3):295-304 - PubMed
  92. Fertil Steril. 2012 Jul;98(1):178-84 - PubMed
  93. Mol Hum Reprod. 2005 Jul;11(7):489-94 - PubMed
  94. Nat Rev Mol Cell Biol. 2002 May;3(5):349-63 - PubMed
  95. PLoS One. 2013;8(3):e57901 - PubMed
  96. Mol Hum Reprod. 1997 Aug;3(8):685-91 - PubMed
  97. Gynecol Endocrinol. 2007 Sep;23(9):541-6 - PubMed
  98. Obstet Gynecol Clin North Am. 2006 Mar;33(1):13-39 - PubMed
  99. J Cell Biol. 1993 Jun;121(5):1165-72 - PubMed
  100. Biochim Biophys Acta. 1990 Jun 1;1032(1):79-87 - PubMed
  101. Hum Reprod. 2006 Jul;21(7):1869-77 - PubMed
  102. Exp Biol Med (Maywood). 2014 Mar;239(3):272-83 - PubMed
  103. PLoS One. 2013 Nov 08;8(11):e79838 - PubMed
  104. Nat Rev Cancer. 2010 Feb;10(2):116-29 - PubMed
  105. Biol Reprod. 2012 Apr 19;86(4):116 - PubMed
  106. Fertil Steril. 2011 Jan;95(1):247-53 - PubMed
  107. Am J Obstet Gynecol. 1996 Aug;175(2):411-9 - PubMed
  108. J Invest Dermatol. 2011 Jan;131(1):84-98 - PubMed
  109. Am J Obstet Gynecol. 2010 Mar;202(3):289.e1-9 - PubMed
  110. Biochim Biophys Acta. 1989 Jul 28;989(1):1-10 - PubMed
  111. Contraception. 2010 Sep;82(3):301-8 - PubMed
  112. Matrix Biol. 2012 Sep-Oct;31(7-8):389-97 - PubMed
  113. J Clin Endocrinol Metab. 2001 Nov;86(11):5593-9 - PubMed
  114. Fertil Steril. 2012 Nov;98(5):1299-307 - PubMed
  115. J Biol Chem. 2004 Jun 4;279(23):24307-12 - PubMed
  116. Toxicol Appl Pharmacol. 2005 Jun 15;205(3):213-24 - PubMed
  117. J Cell Biochem. 2003 Oct 1;90(2):397-407 - PubMed
  118. Endocr Rev. 2003 Dec;24(6):737-64 - PubMed
  119. J Biol Chem. 1995 Sep 1;270(35):20712-6 - PubMed
  120. Hum Reprod. 2012 Feb;27(2):427-35 - PubMed

Publication Types